Males With BRCA Mutations Have Increased Risk of Certain Cancers
Increased incidence of malignant disease, specifically prostate, melanoma, pancreas, breast cancers
Nonoptimized Drug Therapy Costs More Than $500 Billion Annually
After initial Rx use, average cost of individual having treatment failure, new medical problem over $2,000
Volumetric Laser Endomicroscopy Helps ID Barrett’s Regions
High agreement among reviewers seen in 80 percent of quadrants
TFs Operate Across Gene Loci Within Disease Phenotypes
Epstein-Barr virus EBNA2 protein binds to multiple loci of genome, increasing risk of 7 serious diseases
Adjuvant Pembrolizumab Beneficial in Stage III Melanoma
Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up
Recommendations Developed on Gender Equity in Medicine
ACP supports equitable physician compensation based on comparable work at each stage of career
Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC
And, nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden
Adherence to ACS Guidelines Linked to Survival in Colon Cancer
Lower risk of death, improved disease-free survival for ACS guideline score of 5 to 6 versus 0 to 1
Negative Affect That Lingers Tied to Health 10 Years Later
Higher levels of lingering negative affect linked to more chronic conditions, worse functional limitations
No Higher Cancer Risk Seen for Heart Failure Patients
After a median 20 years of follow-up, heart failure not associated with cancer incidence
